$IRIX Cashflow Statement | Understand Stock

$IRIX

$0.72 -$0.02 (2.92%) Close

$IRIX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jan 3, 2026	FY2025 12 months to Dec 28, 2024	FY2024 12 months to Dec 30, 2023	FY2023 12 months to Dec 31, 2022	FY2022 12 months to Jan 1, 2022
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on PPP loan forgiveness
Loss on inventory write-down
Loss on extinguishment of convertible note payable
Depreciation and amortization
Amortization of operating lease right-of-use assets
Loss on disposal of property and equipment
Accretion of original issue discount
Amortization of debt issuance costs
Stock-based compensation
Provision for doubtful accounts
Provision for credit losses

Changes in operating assets and liabilities:
Accounts receivable
Receivable from related party
Inventories
Prepaid expenses and other current assets
Operating lease right-of-use assets
Other long-term assets
Accounts payable
Payable to related party
Accrued compensation
Accrued expenses
Accrued warranty
Deferred revenue
Operating lease liabilities
Other long-term liabilities
Other liabilities

Net cash used in operating activities
Investing activities:
Acquisition of property and equipment
Cash paid for business combination, net
Net cash used in investing activities

Financing activities:
Proceeds from issuance of common stock, net of issuance costs
Net proceeds from issuance of convertible note payable
Payments on note payable
Cash paid for debt issuance costs
Proceeds for stock option exercises
Payments on convertible note payable
Proceeds from issuance of Series B convertible preferred stock
Taxes paid related to net share settlements of equity awards
Net cash provided by financing activities

Effect of foreign exchange rate changes
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental disclosure of cash flow information:
Cash paid (refunded) during the period for income taxes
Supplemental disclosure of non-cash activities:
Transfer of inventory to property and equipment
ROU assets obtained with the modification of operating lease
ROU assets obtained with extension of operating lease
Debt issuance cost
Issuance of common shares in connection to paydown of accrued interest payable
Issuance of common shares in conjunction with extinguishment of convertible note payable
ROU assets obtained with acquisition of operating lease
Issuance of incentive shares under convertible note payable

Comments